Biomarker Landscape in Cancer Research
- 1st Edition - June 18, 2025
- Editors: Ranjita Shegokar, Yashwant Pathak
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 3 3 9 0 2 - 8
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 3 3 9 0 3 - 5
Biomarker Landscape in Cancer Research examines the impact of early detection, predication of aggressiveness, and the determination of the best treatment for cancers. With a strong… Read more
Biomarker Landscape in Cancer Research examines the impact of early detection, predication of aggressiveness, and the determination of the best treatment for cancers. With a strong focus on the status, challenges, and prospects of biomarker measurements' tools and technology, the book also examines clinical translation-related knowledge and the prognosis of different organ related cancers. In 21 chapters, it describes current and new diagnostic tools in twenty different cancers and explores how innovations in the cancer diagnostic space could make cancer screening and early detection more straightforward.
This book is a timely and valuable resource for health professionals, scientists and researchers, health practitioners, students, and all those who wish to broaden their knowledge in the allied field.
This book is a timely and valuable resource for health professionals, scientists and researchers, health practitioners, students, and all those who wish to broaden their knowledge in the allied field.
- Provides essential information on the most recent developments in the biomarker landscape of different cancer types
- Explains current technologies and their applications in the biomarker cancer research landscape
- Includes contributions from oncologists, biomedical engineers, pharmaceutical scientists, and manufacturers
Researchers working across the biosciences in fields of oncology
1. Biomarker landscape in Liver cancer: current and new
2. Biomarker landscape in Pancrea cancer : current and new
3. Biomarker landscape in in Heart cancer : current and new
4. Biomarker landscape in Bone cancer : current and new
5. Biomarker landscape in Spleen cancer: current and new
6. Biomarker landscape in ENT cancer : current and new
7. Biomarker landscape in Brain/CNS cancer: current and new
8. Biomarker landscape in Skin cancer: current and new
9. Biomarker landscape in Lung cancer: current and new
10. Biomarker landscape in Thorax cancer: current and new
11. Biomarker landscape in Thyroid cancer: current and new
12. Biomarker landscape in Kidney-adrenal: current and new
13. Biomarker landscape in Urinary track: current and new
14. Biomarker landscape in Breast: current and new
15. Biomarker landscape in Colorectal: current and new
16. Biomarker landscape in Blood cancer: current and new
17. Biomarker landscape in Prostate cancer: current and new
18. Biomarker landscape in Ovarian cancer: current and new
19. Biomarker landscape in Stomach and intestinal cancer: current and new
20. Biomarker landscape in Plura and peritonium Cancer: current and new
21. Biomarker trends in ocular cancer
2. Biomarker landscape in Pancrea cancer : current and new
3. Biomarker landscape in in Heart cancer : current and new
4. Biomarker landscape in Bone cancer : current and new
5. Biomarker landscape in Spleen cancer: current and new
6. Biomarker landscape in ENT cancer : current and new
7. Biomarker landscape in Brain/CNS cancer: current and new
8. Biomarker landscape in Skin cancer: current and new
9. Biomarker landscape in Lung cancer: current and new
10. Biomarker landscape in Thorax cancer: current and new
11. Biomarker landscape in Thyroid cancer: current and new
12. Biomarker landscape in Kidney-adrenal: current and new
13. Biomarker landscape in Urinary track: current and new
14. Biomarker landscape in Breast: current and new
15. Biomarker landscape in Colorectal: current and new
16. Biomarker landscape in Blood cancer: current and new
17. Biomarker landscape in Prostate cancer: current and new
18. Biomarker landscape in Ovarian cancer: current and new
19. Biomarker landscape in Stomach and intestinal cancer: current and new
20. Biomarker landscape in Plura and peritonium Cancer: current and new
21. Biomarker trends in ocular cancer
- Edition: 1
- Published: June 18, 2025
- Language: English
RS
Ranjita Shegokar
Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)
Affiliations and expertise
Postdoctoral Researcher, Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics, Free University of Berlin, GermanyYP
Yashwant Pathak
Yashwant Pathak is a Professor and Associate Dean for faculty affairs at the Taneja College of Pharmacy at the University of South Florida, Tampa, USA. Prof. Pathak is also an Adjunct Professor at the Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia. His area of research is in health care education, nanotechnology, drug delivery systems, and nutraceuticals.
Affiliations and expertise
Professor and Associate Dean, Faculty Affairs, College of Pharmacy, University of South Florida, Tampa, USARead Biomarker Landscape in Cancer Research on ScienceDirect